HEALTH GAINS AND FINANCIAL PROTECTION FROM PNEUMOCOCCAL VACCINATION AND PNEUMONIA TREATMENT IN ETHIOPIA: RESULTS FROM AN EXTENDED COST-EFFECTIVENESS ANALYSIS.

Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis.

BACKGROUND:Pneumonia and pneumococcal disease cause a large disease burden in resource-constrained settings.We pursue an extended cost-effectiveness analysis (ECEA) of two fully publicly financed interventions in Ethiopia: pneumococcal vaccination for newborns and pneumonia treatment for under-five children in Ethiopia.METHODS:We apply ECEA methods

read more


Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model

Feng-Yun J Huang,1 Te-Wei Lee,2 Chih-Hsien Chang,2 Liang-Cheng Chen,2 Wei-Hsin Hsu,2 Chien-Wen Chang,1 Jem-Mau Lo1 1Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan; 2Institute of Nuclear Energy Research, Longtan, Taiwan Purpose: In this study, the 188Re-labeled PEGylated nanoliposome (

read more